| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 02/13/2002 | EP1178988A1 Compounds and therapeutic methods |
| 02/13/2002 | EP1178983A1 Indole-type derivatives as inhibitors of p38 kinase |
| 02/13/2002 | EP1178958A2 N-cyanomethyl amides as protease inhibitors |
| 02/13/2002 | EP1178954A1 A structure-based approach to design inhibitors of protein-processivity factor interactions |
| 02/13/2002 | CN1335889A Chimeric gene encoding the antigenic determinants of four proteins of L.INFANTUM |
| 02/13/2002 | CN1335841A N-(iminomethyl) amine derivatives, their preparation, their use as medicines and compositions containing them |
| 02/13/2002 | CN1335771A N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 02/13/2002 | CN1335131A Local administration preparation |
| 02/12/2002 | US6346542 Applying racemic mixture; controlling fleas and ticks; veterinary medicine |
| 02/07/2002 | WO2002010216A2 Proteins and nucleic acids encoding same |
| 02/07/2002 | WO2002009686A2 Cdc25 phosphatase inhibitors |
| 02/07/2002 | WO2001042449A3 Methods for introducing genes into mammalian subjects |
| 02/07/2002 | US20020016361 Beta-amino acid nitrile derivatives as cathepsin K inhibitors |
| 02/07/2002 | US20020016301 Preventing or treating emesis associated with a macrolide antibiotic comprising administering a Substance P antagonist, such as (2S,3S)-3-(5-tert-butyl-2-methoxybenzyl)amino-2-(3 -trifluromethoxylphenyl)piperidine |
| 02/07/2002 | US20020016297 4-oxo-2- ureido-1,4,5,6,-tetrahydro-pyrimidine derivatives |
| 02/07/2002 | US20020015706 Vaccine conjugate for producing active immunity in a bird administered in ovo; live bacteria or protozoa with a neutralizing antibody or antibody fragment bound to it |
| 02/07/2002 | DE10032877A1 Anthelmintika zur Verhinderung von parasitären Infektionen bei Mensch und Tier III Anthelmintics for the prevention of parasitic infections in humans and animals III |
| 02/07/2002 | CA2417349A1 Novel proteins and nucleic acids encoding same |
| 02/07/2002 | CA2417262A1 Cdc25 phosphatase inhibitors |
| 02/06/2002 | EP1177296A2 Extracellular matrix and adhesion-associated proteins |
| 02/06/2002 | EP1177197A2 Polyamines and their use in therapy |
| 02/06/2002 | EP1177191A1 Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa |
| 02/06/2002 | CN1334728A Palladium-substd. bacteriochlorophll derivatives and use thereof |
| 02/06/2002 | CN1334726A Hydroxy diphenyl urea sulfonamides as IL-8 receptor antagonists |
| 02/05/2002 | US6344552 Compositions and methods comprising DNA sequences encoding B. burgdorferi polypeptides |
| 02/05/2002 | US6344202 Nucleotide sequence encodes major outer membrane proteins, generates antibodies that react with promoter sequence for expression in the host; drugs, vaccines |
| 01/31/2002 | WO2002008420A2 A method of down-regulating gene expression |
| 01/31/2002 | WO2002008396A2 Human proteases |
| 01/31/2002 | WO2002008255A2 Cell cycle proteins and mitosis-associated molecules |
| 01/31/2002 | WO2002008235A1 Medicament for oral application, containing aminopropyl phosphonic acid esters as an active ingredient |
| 01/31/2002 | WO2002008217A2 COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS |
| 01/31/2002 | WO2002008189A1 Compounds and inhibitors of phospholipases |
| 01/31/2002 | WO2001039778A3 Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans |
| 01/31/2002 | US20020013484 Water solubility; prodrug containing polyether oligomer |
| 01/31/2002 | US20020013341 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, Bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition |
| 01/31/2002 | US20020013326 For controlling harmful insects, acarina and nematodes |
| 01/31/2002 | US20020013306 Terpyridine-platinum(ii) complexes |
| 01/31/2002 | US20020012661 Methods for introducing genes into mammalian subjects |
| 01/31/2002 | CA2417127A1 Compounds and inhibitors of phospholipases |
| 01/31/2002 | CA2416691A1 Proteases |
| 01/31/2002 | CA2415077A1 Cell cycle proteins and mitosis-associated molecules |
| 01/30/2002 | EP1175497A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 01/30/2002 | EP1175446A1 Human antibodies that bind human il-12 and methods for producing |
| 01/30/2002 | EP1175435A1 Cephaibols, novel antiparasitics from acremonium tubakii, method for the production and the utilization thereof |
| 01/30/2002 | EP1175226A1 Lipoglycan compositions and methods of treating parasitic infections |
| 01/30/2002 | EP1175223A2 Methods and compositions for modulating an immune response |
| 01/30/2002 | EP1175216A2 Antimalarian agents for the treatment of asthma |
| 01/30/2002 | CN1333832A Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/30/2002 | CN1078463C Ionene polymers and anthelmintics in animals |
| 01/29/2002 | US6342509 Antiasthmatics, antihistamines or bronchodialators |
| 01/29/2002 | US6342482 Hair conditioners with spinosyn for killing lice |
| 01/24/2002 | WO2002006257A1 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (iii) |
| 01/24/2002 | WO2002006256A1 Heterocyclic fluoroalkenyl thioethers (ii) |
| 01/24/2002 | WO2002006189A2 Aniline derivatives |
| 01/24/2002 | WO2002005649A1 Parasiticide and parasitic method for globefish |
| 01/24/2002 | WO2001046258A3 Transporters and ion channels |
| 01/24/2002 | WO2001041785A3 Enzyme treatment for infection |
| 01/24/2002 | US20020010098 Insecticides, nematodicides |
| 01/24/2002 | DE10034137A1 Wirkstoffkombinationen aus 3-Iodo-2-propinyl-butylcarbamat und einem oder mehreren 4-Hydroxybenzoesäureestern und Zubereitungen, solche Wirkstoffkombinationen enthaltend Active compound combinations of 3-iodo-2-propynyl butyl carbamate and one or more 4-hydroxybenzoic acid and preparations such active ingredient combinations |
| 01/24/2002 | DE10034136A1 Wirkstoffkombinationen aus 3-Iodo-2-propinyl-butylcarbamat, einem oder mehreren 4-Hydroxybenzoesäureester und Phenoxyethanol und Zubereitungen, solche Wirkstoffkomibnationen enthaltend Active compound combinations of 3-iodo-2-propynyl butyl carbamate, one or more 4-hydroxybenzoic acid esters and phenoxyethanol and preparations containing such Wirkstoffkomibnationen |
| 01/24/2002 | DE10034132A1 Heterocyclische Fluoralkenylthioether (lll) Heterocyclic fluoroalkenyl thioethers (III) |
| 01/24/2002 | DE10034131A1 Heterocyclische Fluoralkenylthioether (II) Heterocyclic fluoroalkenyl thioethers (II) |
| 01/23/2002 | EP1173767A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/23/2002 | EP1173477A1 49 human secreted proteins |
| 01/23/2002 | EP1173468A1 Integrin receptor antagonists |
| 01/23/2002 | EP1173170A1 Pyrrolidine modulators of chemokine receptor activity |
| 01/23/2002 | CN1332626A Inhalation system |
| 01/23/2002 | CN1331970A Application of Mandelit in preparing medicine for human and animal toxoplasma disease |
| 01/22/2002 | US6340700 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 01/22/2002 | US6340685 Antiinflammatory agents |
| 01/22/2002 | US6340671 Stable compositions for parenteral administration and their use |
| 01/22/2002 | CA2057711C Antibiotic agent |
| 01/17/2002 | WO2002004612A2 Drug metabolizing enzymes |
| 01/17/2002 | WO2002003896A1 Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
| 01/17/2002 | WO2001019407A3 Taxane prodrugs |
| 01/17/2002 | WO2001010468A3 Drug-carrier complexes and methods of use thereof |
| 01/17/2002 | WO2001007471A3 Cell cycle and proliferation proteins |
| 01/17/2002 | WO2001007087A3 Enzyme catalyzed anti-infective therapeutic agents |
| 01/17/2002 | WO2000078953A3 Human transport proteins |
| 01/17/2002 | WO2000078952A3 Human rna metabolism proteins (rmep) |
| 01/17/2002 | US20020006408 Vaccines against eimeria mediated disorder |
| 01/17/2002 | DE10032880A1 Anthelmintika zur Verhinderung von parasitären Infektionen bei Mensch und Tier IV Anthelmintics for the prevention of parasitic infections in humans and animals IV |
| 01/17/2002 | DE10032879A1 Anthelmintika zur Verhinderung von parasitären Infektionen bei Mensch und Tier II Anthelmintics for the prevention of parasitic infections in humans and animals II |
| 01/17/2002 | DE10032878A1 Anthelmintika zur Verhinderung von parasitären Infektionen bei Mensch und Tier Anthelmintics for the prevention of parasitic infections in humans and animals |
| 01/17/2002 | CA2416050A1 Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
| 01/17/2002 | CA2414387A1 Drug metabolizing enzymes |
| 01/16/2002 | EP1172103A2 Combination of 3-iodo-2-propynyl-butylcarbamate esters and one or more hydroxybenzoic acids |
| 01/16/2002 | EP1172102A2 Combination of 3-iodo-2-propynyl-butylcarbamate esters and one or more hydroxybenzoic acids and phenoxyethanol |
| 01/16/2002 | EP1171457A1 46 human secreted proteins |
| 01/16/2002 | EP1171435A2 Pyrimidine-2-one derivatives as integrin receptor ligands |
| 01/16/2002 | EP1171127A2 Pharmaceutical compositions containing pyridine or pyrimidine derivatives for inhibition of cytokine production and secretion |
| 01/16/2002 | EP1171113A1 Compounds useful as phosphotyrosine mimics |
| 01/16/2002 | EP1171108A1 Combination preparation for treating malaria |
| 01/16/2002 | CN1331601A Antiprotozoal saponins |
| 01/16/2002 | CN1331595A Triazine compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
| 01/16/2002 | CN1331594A Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
| 01/15/2002 | US6339073 Uses of nicotinamide adenine dinucleotide and its derivatives for treatment of malignant and infectious diseases |
| 01/10/2002 | WO2002002634A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/10/2002 | WO2002002633A2 Transporters and ion channels |
| 01/10/2002 | WO2002002603A2 Protein modification and maintenance molecules |